SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-18-000087
Filing Date
2018-02-15
Accepted
2018-02-15 15:58:32
Documents
39
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 12-31-2017 form_10-q.htm 10-Q 256005
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5977
3 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3626
4 GRAPHIC angiosoma_logo.jpg GRAPHIC 29521
  Complete submission text file 0001161697-18-000087.txt   1489033

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE soan-20171231.xml EX-101.INS 179093
6 XBRL SCHEMA FILE soan-20171231.xsd EX-101.SCH 21921
7 XBRL CALCULATION FILE soan-20171231_cal.xml EX-101.CAL 29911
8 XBRL DEFINITION FILE soan-20171231_def.xml EX-101.DEF 52012
9 XBRL LABEL FILE soan-20171231_lab.xml EX-101.LAB 157681
10 XBRL PRESENTATION FILE soan-20171231_pre.xml EX-101.PRE 112982
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 18617623
SIC: 2834 Pharmaceutical Preparations